Jacobs John C bought NVAX

January 23, 2024 · Form 4 insider transaction

Jacobs John C bought 83,197 shares of Novavax, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

83,197

Price

N/A

Total value

N/A

InsiderJacobs John C

RoleOfficer, Director

CompanyNovavax, Inc. (NVAX)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateJanuary 23, 2024

Filing dateJanuary 25, 2024

Shares owned after83,197

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

View the original Form 4 on SEC EDGAR